“Did you see what they passed in Congress two days ago? It’s really important,” Robbins said (1), referring to the ...

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the ...